SNDX
SNDX
NASDAQ · Biotechnology

Syndax Pharmaceuticals Inc

$19.11
-2.32 (-10.83%)
As of May 9, 1:32 AM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 19 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +28.2% upside
Low Target $15.15
Average Target $24.49
High Target $32.88
Current Price $19.11
Current
$19.11
Target
$24.49
$15.15 $24.49 avg $32.88
Scenario Analysis
Bear Case
$15.15
-20.7%
Low target
Base Case
$24.49
+28.2%
Avg target
Bull Case
$32.88
+72.1%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$25.59
-25.3% from high
52-Week Low
$8.58
+122.7% from low
Target vs 52W High
$24.49
-4.3% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.63
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
Strong Buy 28 96% $143.40 +41.5%